Sharps Technology Cash Flow from Operating Activities 2022-2025 | STSS

Sharps Technology cash flow from operating activities from 2022 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.

Sharps Technology Cash Flow from Operating Activities 2022-2025 | STSS

Sharps Technology cash flow from operating activities from 2022 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$225.2B
Boston Scientific (BSX)$151.9B
Stryker (SYK)$144.9B
EssilorLuxottica (ESLOY)$142.5B
Medtronic (MDT)$119.1B
Lonza Group Ag (LZAGY)$48B
Haleon (HLN)$43.5B
ResMed (RMD)$42.2B
GE HealthCare Technologies (GEHC)$34.4B
Agilent Technologies (A)$34.2B
Terumo (TRUMY)$27.9B
Koninklijke Philips (PHG)$26.3B
Insulet (PODD)$21.7B
Zimmer Biomet Holdings (ZBH)$20.4B
Smith & Nephew SNATS (SNN)$16.1B
Baxter (BAX)$12.4B
Sunny Optical Technology (SNPTF)$10.8B
Demant (WILYY)$8.1B
Bio-Rad Laboratories (BIO)$7.8B
Lantheus Holdings (LNTH)$3.7B
Envista Holdings (NVST)$3.6B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Prestige Consumer Healthcare (PBH)$3.3B
Perrigo (PRGO)$3.3B
ICU Medical (ICUI)$2.8B
Haemonetics (HAE)$2.6B
LeMaitre Vascular (LMAT)$2.2B
Curaleaf Holdings (CURLF)$2.1B
Green Thumb Industries (GTBIF)$1.9B
QuidelOrtho (QDEL)$1.8B